of Defense): FDA Warning Letter Summit Research Peptides (Dec 2024): FDA Warning Letters search page: BPC-157 WADA prohibited substance The human trials problem only 1 human study out of 544 articles reviewed American Journal of Sports Medicine systematic review (Vasireddi et al., 2025 544 articles screened, 35 preclinical, 1 clinical): Arnold's Pump Club plain-language summary of that review: The single research group problem STAT News / Undark investigation (Feb 2026 "nearly all data comes from a single research group"): NAD therapy not approved for addiction, evidence is small studies only WebMD: Addiction Center: PAWS Post-Acute Withdrawal Syndrome Hazelden Betty Ford: The Personality Sobriety Stole From Me (And What I Found Underneath) Everyone expects sobriety to reveal the real you calmer, freer, finally yourself
Gagnon, C
Ghrelin/Secretagogues (like Ipamorelin) which act as the accelerator pedal
Evidence indicates that GLP-1RAs preserve mitochondrial function by enhancing calcium uptake, improving membrane potential, increasing ATP production, promoting mitochondrial biogenesis, and reducing oxidative stress and apoptosis (172,173)
China is the major hub for GLP-1 API manufacturing and hosts by far the largest number of semaglutide API manufacturers - ahead of companies in India, Europe, and the USA
Am J Manag Care
